Emilio Montserrat

13.0k total citations · 1 hit paper
84 papers, 4.2k citations indexed

About

Emilio Montserrat is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Emilio Montserrat has authored 84 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pathology and Forensic Medicine, 47 papers in Genetics and 32 papers in Hematology. Recurrent topics in Emilio Montserrat's work include Lymphoma Diagnosis and Treatment (51 papers), Chronic Lymphocytic Leukemia Research (36 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Emilio Montserrat is often cited by papers focused on Lymphoma Diagnosis and Treatment (51 papers), Chronic Lymphocytic Leukemia Research (36 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Emilio Montserrat collaborates with scholars based in Spain, United Kingdom and United States. Emilio Montserrat's co-authors include C Rozmán, Elı́as Campo, Francisco Cervantes, Núria Viñolas, Antonio Cardesa, Magda Pinyol, Pedro L. Fernández, Neus Villamor, Pedro Jares and Sı́lvia Beà and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Emilio Montserrat

84 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Lymphocytic Leukemia

1995 654 citations C Rozmán, Emilio Montserrat profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emilio Montserrat Spain	30	2.4k	2.0k	1.4k	1.2k	1.1k	84	4.2k
Gerassimos A. Pangalis Greece	34	2.4k 1.0×	2.6k 1.3×	1.1k 0.8×	1.2k 1.0×	1.3k 1.2×	174	4.7k
Preetesh Jain United States	32	2.2k 0.9×	1.5k 0.7×	1.4k 1.1×	846 0.7×	1.0k 0.9×	181	3.7k
Thierry Lamy France	41	2.1k 0.9×	2.6k 1.3×	1.9k 1.4×	2.6k 2.1×	2.3k 2.1×	177	6.4k
Kazimierz Kuliczkowski Poland	29	1.1k 0.5×	794 0.4×	1.2k 0.9×	978 0.8×	1.2k 1.1×	202	3.5k
Giovanni Del Poeta Italy	39	2.2k 0.9×	1.5k 0.7×	2.7k 2.0×	1.4k 1.1×	795 0.7×	189	5.5k
Sergej Konoplev United States	35	1.2k 0.5×	964 0.5×	2.2k 1.6×	1.1k 0.9×	1.4k 1.3×	154	4.6k
EJ Freireich United States	33	1.4k 0.6×	996 0.5×	1.8k 1.3×	515 0.4×	791 0.7×	59	3.4k
Monica Bocchia Italy	28	1.1k 0.4×	850 0.4×	1.3k 0.9×	964 0.8×	1.0k 0.9×	179	2.9k
Miloslav Beran United States	38	2.6k 1.1×	1.1k 0.5×	3.3k 2.5×	744 0.6×	1.1k 1.0×	106	5.6k
Stefan Faderl United States	26	1.7k 0.7×	1.0k 0.5×	2.0k 1.4×	743 0.6×	548 0.5×	115	3.6k

Countries citing papers authored by Emilio Montserrat

Since Specialization

Citations

This map shows the geographic impact of Emilio Montserrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Montserrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Montserrat more than expected).

Fields of papers citing papers by Emilio Montserrat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio Montserrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Montserrat. The network helps show where Emilio Montserrat may publish in the future.

Co-authorship network of co-authors of Emilio Montserrat

This figure shows the co-authorship network connecting the top 25 collaborators of Emilio Montserrat. A scholar is included among the top collaborators of Emilio Montserrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilio Montserrat. Emilio Montserrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cervantes, Francisco, Juan Carlos Hernández‐Boluda, J Odriozola, et al.. (2003). Imatinib mesylate (STI571) treatment in patients with chronic‐phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation. British Journal of Haematology. 120(3). 500–504. 8 indexed citations

Hernández‐Boluda, Juan Carlos, Francisco Cervantes, Dolors Colomer, et al.. (2003). Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis. Experimental Hematology. 31(3). 204–210. 22 indexed citations

Rafel, Montserrat, et al.. (2000). Deoxycoformycin in the treatment of patients with hairy cell leukemia. Cancer. 88(2). 352–357. 45 indexed citations

Montoto, Silvia, Mireia Camós, Armando López‐Guillermo, et al.. (2000). Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C‐MOPP/ABV) as first‐line treatment for patients with advanced hodgkin disease. Cancer. 88(9). 2142–2148. 1 indexed citations

Pinyol, Magda, Luís Hernández, Antonio Martı́nez, et al.. (2000). INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene. American Journal Of Pathology. 156(6). 1987–1996. 74 indexed citations

Álvarez‐Larrán, Alberto, Armando López‐Guillermo, Rosa Miquel, & Emilio Montserrat. (1999). Linfoma T subcutáneo paniculítico. Medicina Clínica. 113(3). 1 indexed citations

Martı́nez, Carmen, Álvaro Urbano-Ispizúa, C Rozmán, et al.. (1999). Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation. Experimental Hematology. 27(3). 561–568. 84 indexed citations

Cobo, Francesc, Magda Pinyol, Francesc Bosch, et al.. (1999). Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient. The Journal of Pathology. 189(2). 288–293. 41 indexed citations

Sans, Miquel, Victòria Andreu, Josep M. Bordas, et al.. (1998). Usefulness of laparoscopy with liver biopsy in the assessment of liver involvement at diagnosis of Hodgkin's and non-Hodgkin's lymphomas. Gastrointestinal Endoscopy. 47(5). 391–395. 12 indexed citations

10.

Bellosillo, Beatríz, Maria Piqué, Montserrat Barragán, et al.. (1998). Aspirin and Salicylate Induce Apoptosis and Activation of Caspases in B-Cell Chronic Lymphocytic Leukemia Cells. Blood. 92(4). 1406–1414. 16 indexed citations

11.

Montserrat, Emilio. (1997). Chronic lymphoproliferative disorders. Current Opinion in Oncology. 9(1). 34–42. 41 indexed citations

12.

Montserrat, Emilio, Neus Villamor, Joan Carles Reverter, et al.. (1996). Bone marrow assessment in B‐cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients. British Journal of Haematology. 93(1). 111–116. 25 indexed citations

13.

Cobo, Francesc, F. Cervantes, Carmen Martı́nez, et al.. (1995). Multiple Myeloma Following Essential Thrombocythemia. Leukemia & lymphoma. 20(1-2). 177–179. 11 indexed citations

14.

Tàssies, Dolors, Emilio Montserrat, Joan Carles Reverter, et al.. (1995). Myelomonocytic antigens in B-cell chronic lymphocytic leukemia. Leukemia Research. 19(11). 841–848. 19 indexed citations

15.

Montserrat, Emilio, Neus Villamor, Álvaro Urbano-Ispizúa, Josep‐María Ribera, & C Rozmán. (1991). Alpha interferon in chronic lymphocytic leukaemia. European Journal of Cancer and Clinical Oncology. 27. S74–S77. 8 indexed citations

16.

Molica, Stefano, Joan Carles Reverter, Antonio Alberti, & Emilio Montserrat. (1990). Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: Analysis of their clinical significance. European Journal Of Haematology. 44(5). 277–281. 18 indexed citations

17.

Montserrat, Emilio, et al.. (1990). Efficacy of ABVD Therapy in Resistant Hodgkin's Disease. Leukemia & lymphoma. 1(2). 119–122. 1 indexed citations

18.

Gale, Robert Peter, Jacques‐Louis Binet, Daniel Catovsky, et al.. (1989). 4th International workshop on CLL. Leukemia Research. 13(6). 505–510. 2 indexed citations

19.

Pereira, Arturo, et al.. (1987). Non‐hodgkin's lymphoma of unfavourable histology: A multivariate analysis of factors predicting the response to chop. Hematological Oncology. 5(3). 203–211. 7 indexed citations

20.

Montserrat, Emilio, et al.. (1986). Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. British Journal of Haematology. 62(3). 567–575. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact